(Q40922425)

24 September 2017

1 reference

title

Scleroderma. Clinical problems. The lungs (English)

1 reference

24 September 2017

Silver RM

1

1 reference

24 September 2017

language of work or name

1 reference

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

22

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

825-840

1 reference

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Long‐term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Cytokines and pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Structural features of interstitial lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Lung Involvement in Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Single lung transplantation in patients with systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Transforming growth factor beta within fibrotic scleroderma lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Isolated diffusing capacity reduction in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Fibroblast growth factors in connective tissue disease associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

Pulmonary vascular changes in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

The pulmonary pathologic manifestations of the CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970303-3

7 January 2021

10.1016/S0889-857X(05)70303-3

Identifiers

DOI

1 reference

24 September 2017

1 reference